Novel mechanisms in accelerated vascular calcification in renal disease patients

Current Opinion in Nephrology and Hypertension

Volumn 11, Issue 4, 2002, Pages 437-443

  Demer, Linda L ^a   Tintut, Yin ^a   Parhami, Farhad ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Atherosclerosis; Bone morphogenetic protein; Oxidized lipids; Vascular calcification

Indexed keywords

BONE MORPHOGENETIC PROTEIN; C REACTIVE PROTEIN; CALCIUM ION; CARBOXYLASE; CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPID; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PHOSPHATE; VITAMIN K GROUP; WARFARIN;

ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL CALCIFICATION; BONE DEVELOPMENT; BONE MINERALIZATION; CELL DIFFERENTIATION; DYSLIPIDEMIA; EXTRACELLULAR MATRIX; GENETIC POLYMORPHISM; HEREDITY; HETEROTOPIC OSSIFICATION; HUMAN; INFLAMMATION; KIDNEY DISEASE; KIDNEY FAILURE; MESENCHYME; MINERALIZATION; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OXIDATIVE STRESS; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; UREMIA; ANIMAL; CALCINOSIS; VASCULAR DISEASE;

ANIMAL; CALCINOSIS; HUMAN; KIDNEY DISEASES; VASCULAR DISEASES; ANIMALS; HUMANS;

EID: 0036019492     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-200207000-00011     Document Type: Review

References (59)

1. Cardiac valve calcification in haemodialysis patients: Role of calcium-phosphate metabolism
2. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis
3. Abdominal aortic calcific deposits are an important predictor of vascular morbidity and mortality
4. High coronary artery calcium scores pose an extremely elevated risk for hard events
5. Ossification in atherosclerotic carotid arteries
6. Bone formation in sclerotic arteries
7. Aortic wall mechanics and composition in a transgenic mouse model of Marfan syndrome
8. Bone morphogenetic protein expression in human atherosclerotic lesions
9. Expression of osteopontin messenger RNA by macrophages in atherosclerotic plaques: A possible association with calcification
10. Changes in homeobox-containing gene expression during ectopic bone formation induced by bone morphogenetic protein
11. Osteopontin mRNA is expressed by smooth muscle-derived foam cells in human atherosclerotic lesions of the aorta
12. High expression of genes for calcification-regulating proteins in human atherosclerotic plaques
13. Osteopontin is synthesized by macrophage, smooth muscle, and endothelial cells in primary and restenotic human coronary atherosclerotic plaques
14. Soluble osteopontin and vascular calcification in hemodialysis patients
15. Transcriptional control of osteoblast differentiation
16. Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques
17. Time course of osteopontin, osteocalcin, and osteonectin accumulation and calcification after acute vessel wall injury
18. Apoptosis regulates human vascular calcification in vitro: Evidence for initiation of vascular calcification by apoptotic bodies
19. Serum magnesium level and arterial calcification in end-stage renal disease
20. Historical perspective on management of calcium and phosphorus metabolism in chronic renal failure
21. Phosphate regulation of vascular smooth muscle cell calcification
22. Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation: A possible explanation for the paradox of arterial calcification in osteoporotic patients
23. 8-Isoprostaglandin E2 enhances RANKL-dependent osteoclastic potential of marrow hematopoietic precursors via the cAMP pathway
24. Atherogenic high-fat diet reduces bone mineralization in mice
25. Association of multiple risk factors and insulin resistance with increased prevalence of asymptomatic coronary artery disease by an electron-beam computed tomographic study
26. Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography
27. Familial aggregation of coronary artery calcium in families with type 2 diabetes
28. Atherogenic lipoproteins in end-stage renal disease
29. Significant association between the progression of coronary artery calcification and dyslipidemia in patients on chronic hemodialysis
30. Coronary calcification and cardiac events after percutaneous intervention in dialysis patients
31. Oxidative stress modulates osteoblastic differentiation of vascular and bone cells
32. Total antioxidant status and coronary artery calcification in type 1 diabetes
33. Medial artery calcification: A neglected harbinger of cardiovascular complications in non-insulin dependent diabetes mellitus
34. Monocyte/macrophage regulation of vascular calcification in vitro
35. The involvement of matrix glycoproteins in vascular calcification and fibrosis: An immunohistochemical study
36. Expression of IL-5 alters bone metabolism and induces ossification of the spleen in transgenic mice
37. Association of inflammation and malnutrition with cardiac valve calcification in continuous ambulatory peritoneal dialysis patients
38. Gender- and age-dependent relationships between the E-selectin S128R polymorphism and coronary artery calcification
39. Coronary artery complicated lesion area is related to functional polymorphism of matrix metalloproteinase 9 gene: An autopsy study
40. Disulfide bridge conformers of mature BMP are inhibitors for heterotopic ossification
41. An immuno-light, and electronmicroscopic study of the expression of bone morphogenetic protein-2 during the process of ectopic bone formation in the rat
42. Role of vitamin K and vitamin K-dependent proteins in vascular calcification
43. Matrix GLA protein modulates differentiation induced by bone morphogenetic protein-2 in C3H10T1/2 cells
44. Matrix GLA protein, a regulatory protein for bone morphogenetic protein-2
45. Warfarin-induced artery calcification is accelerated by growth and vitamin D
46. A polymorphism of the human matrix gamma-carboxyglutamic acid protein promoter alters binding of an activating protein-1 complex and is associated with altered transcription and serum levels
47. Vascular calcification in chronic renal failure
48. Leptin enhances the calcification of vascular cells: Artery wall as a target of leptin
49. Bisphosphonates alendronate and ibandronate inhibit artery calcification at doses comparable to those that inhibit bone resorption
50. Receptor activator of NF-kappa B and osteoprotegerin expression by human microvascular endothelial cells, regulation by inflammatory cytokines, and role in human osteoclastogenesis
51. Effects of immunosuppressants on receptor activator of NF-kappaB ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth muscle cells
52. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification
53. Osteoprotegerin inhibits artery calcification induced by warfarin and by vitamin D
54. Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women
55. Bone formation and inflammation in cardiac valves
56. Identification and characterization of calcifying valve cells from human and canine aortic valves
57. Matrix metalloproteinase-2 is associated with tenascin-C in calcific aortic stenosis
58. Electron beam computed tomography for the quantification of aortic valvular calcification